Hereditary Gastrointestinal Cancer Registry banner

Our Team

deb neklason Deborah Neklason, PhD, principal investigator for HGCR and the FAPEST chemoprevention clinical trial, provides the research team with scientific and administrative guidance. Deborah is a molecular geneticist and a member of the Gastrointestinal Cancer Program. Her research focuses on the genetic basis of inherited forms of colon cancer.

Jsammadder Jewel Samadder, MD, principal investigator for the Cancer Prevention Pharmaceuticals clinical trial. Co-investigator for HGCR and the FAPEST chemoprevention clinical trial and is also a gastroenterologist. His clinical interests focus on gastrointestinal cancer syndromes and endoscopic oncology. Dr. Samadder's research focuses on the early detection and prevention of colorectal cancer.

randy burt Randall Burt, MD, founder of HGCR and co-investigator, is a Professor of Internal Medicine Emeritus and Huntsman Cancer Institute Prevention & Outreach Director Emeritus. He is recognized as an international leader in the field of familial colorectal cancer for both clinical care and clinical research.

Megan Keener

Megan Keener, Research coordinator for HGCR. She manages recruitment, enrollment and collection of study materials from participants. She also prepares and maintain regulatory documentation and correspondence with the IRB. Megan also works on the CPP clinical trial & the FAPEST chemoprevention trial. She helps coordinate recruitment, enrollment, and clinical aspects of the trial along with study sample collection and data management.

michelle done Michelle Done, Clinical Research Coordinator for the FAPEST chemoprevention trial and CPP trial, manages recruitment, enrollment and clinical aspects of the trial. Michelle also maintains regulatory documentation, and correspondence with the IRB.

Angela Snow

Angela Snow, MS, manages the molecular lab and provides general oversight.  She is involved in developing methods, performing experiments, analyzing data and reporting for our molecular studies in colorectal cancer and our genetic studies in high risk families.

Austin Wood

Austin Wood, BS, Laboratory Technician, conducts molecular-based experimentation for various studies with HGCR. He is currently analyzing the effect of chemoprevention drugs on RNA transcription levels in polyp and normal duodenal tissues for the FAPEST clinical trial. He is also involved in detecting specific genetic changes by targeted & genomic sequencing, as well as SNP genotyping assays.

Data team
Deb Ma, Stevie Kinnear, Therese Berry, and Andrew Intveld, Information Coordinators, manage and maintain the research databases to provide accurate data for the HGCR research team. Their jobs require a broad range of research knowledge as well as detailed understanding of the research databases and how the various studies relate to each other.